(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide

C164H180F4N28O6 — CID 167653394

IUPAC(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide
SMILESCc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F
InChIInChI=1S/2C28H34N4O.4C27H28FN5O/c2*1-20-9-11-23(12-10-20)22(3)17-30-27(24-7-5-4-6-8-24)28(33)31-26-14-13-25(18-29-26)32-16-15-21(2)19-32;4*1-18-9-10-21(13-24(18)28)19(2)14-30-26(20-7-5-4-6-8-20)27(34)32-25-12-11-22(15-29-25)23-16-31-33(3)17-23/h2*4-14,18,21-22,27,30H,15-17,19H2,1-3H3,(H,29,31,33);4*4-13,15-17,19,26,30H,14H2,1-3H3,(H,29,32,34)/t21-,22?,27-;21-,22+,27+;2*19?,26-;19-,26+;19-,26-/m111110/s1
InChIKeyQXENLJKLMWCDCB-DYZYFDNYSA-N
MW2715.43 g/mol
LogP30.63
Rot. Bonds48

About (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide

(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide (PubChem CID 167653394) has the molecular formula C164H180F4N28O6 and a molecular weight of 2715.43 g/mol. Its IUPAC name is (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide.

Molecular Properties

Compound Name(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide
PubChem CID167653394
Molecular FormulaC164H180F4N28O6
Molecular Weight2715.43 g/mol
Exact Mass2713.46
IUPAC Name(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide
SMILESCc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F
InChIInChI=1S/2C28H34N4O.4C27H28FN5O/c2*1-20-9-11-23(12-10-20)22(3)17-30-27(24-7-5-4-6-8-24)28(33)31-26-14-13-25(18-29-26)32-16-15-21(2)19-32;4*1-18-9-10-21(13-24(18)28)19(2)14-30-26(20-7-5-4-6-8-20)27(34)32-25-12-11-22(15-29-25)23-16-31-33(3)17-23/h2*4-14,18,21-22,27,30H,15-17,19H2,1-3H3,(H,29,31,33);4*4-13,15-17,19,26,30H,14H2,1-3H3,(H,29,32,34)/t21-,22?,27-;21-,22+,27+;2*19?,26-;19-,26+;19-,26-/m111110/s1
InChIKeyQXENLJKLMWCDCB-DYZYFDNYSA-N
XLogP30.63
TPSA401.88 Ų
H-Bond Donors12
H-Bond Acceptors28
Rotatable Bonds48
Heavy Atoms202
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002715.43
LogP ≤ 530.63
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1028

Analyze (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide?
The IUPAC name of (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide (CID 167653394) is (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide.
What is the SMILES notation for (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide?
The canonical SMILES for (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide is Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc(C(C)CN[C@@H](C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.
What is the InChIKey of (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide?
The InChIKey is QXENLJKLMWCDCB-DYZYFDNYSA-N. The full InChI is InChI=1S/2C28H34N4O.4C27H28FN5O/c2*1-20-9-11-23(12-10-20)22(3)17-30-27(24-7-5-4-6-8-24)28(33)31-26-14-13-25(18-29-26)32-16-15-21(2)19-32;4*1-18-9-10-21(13-24(18)28)19(2)14-30-26(20-7-5-4-6-8-20)27(34)32-25-12-11-22(15-29-25)23-16-31-33(3)17-23/h2*4-14,18,21-22,27,30H,15-17,19H2,1-3H3,(H,29,31,33);4*4-13,15-17,19,26,30H,14H2,1-3H3,(H,29,32,34)/t21-,22?,27-;21-,22+,27+;2*19?,26-;19-,26+;19-,26-/m111110/s1.
What are the key properties of (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide?
(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide has a molecular weight of 2715.43 g/mol, XLogP of 30.63, 48 rotatable bonds, 12 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;bis((2R)-2-[2-(3-fluoro-4-methylphenyl)propylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide);(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)propylamino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide is sourced from PubChem (CID 167653394), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).